Picture of Eric Fischer

Eric Sebastian Fischer, Ph.D.

Professor of Biological Chemistry and Molecular Pharmacology

We combine structural biology, cell biology and biochemical reconstitutions to address the molecular workings of multi-protein ubiquitin ligase complexes. In particular, we are interested in protein complexes and pathways that contribute to the control of gene expression and are frequently associated with human disease and cancer.

Research:

The Ubiquitin Proteasome System (UPS) is involved in virtually any cellular process and frequently implicated in human pathologies. Ubiquitin, through the action of a three-enzyme cascade (E1, E2 and E3), is covalently attached to substrate proteins. The posttranslational modification with ubiquitin can serve a multitude of functions depending on the type and length of the ubiquitin chain attached to the substrate, including the control of protein abundance via proteasomal degradation. The human genome encodes for more than 600 E3 ligases, which confer specificity in the ubiquitin signaling cascade. While the process of ubiquitin transfer is well understood, the biological function and molecular mechanisms of the majority of ubiquitin ligases remain obscure.

We combine structural biology, cell biology and biochemical reconstitutions to address the molecular workings of multi-protein ubiquitin ligase complexes. In particular, we are interested in protein complexes and pathways that contribute to the control of gene expression and are frequently associated with human disease and cancer. Intimate understanding of the structure allows us to dissect the complex mechanisms that underlie function and regulation of such molecules and to probe their biology in a cellular context.

We seek to leverage our molecular understanding to propose and test new avenues of therapeutic intervention. We are also interested in small molecules targeting the UPS such as the anti-cancer therapeutics thalidomide and derivatives. As before, we utilize a broad toolset of structural biology, proteomics, cell biology and biochemical reconstitutions to elucidate their activities and precise mode of action.

Address: 

Dana-Farber Cancer Institute

Longwood Center 4312

360 Brookline Ave

Boston, MA 02215

Publications View
Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
Authors: Authors: Fischer ES, Böhm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, Nagel J, Serluca F, Acker V, Lingaraju GM, Tichkule RB, Schebesta M, Forrester WC, Schirle M, Hassiepen U, Ottl J, Hild M, Beckwith RE, Harper JW, Jenkins JL, Thomä NH.
Nature
View full abstract on Pubmed
The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation.
Authors: Authors: Fischer ES, Scrima A, Böhm K, Matsumoto S, Lingaraju GM, Faty M, Yasuda T, Cavadini S, Wakasugi M, Hanaoka F, Iwai S, Gut H, Sugasawa K, Thomä NH.
Cell
View full abstract on Pubmed
Detecting UV-lesions in the genome: The modular CRL4 ubiquitin ligase does it best!
Authors: Authors: Scrima A, Fischer ES, Lingaraju GM, Böhm K, Cavadini S, Thomä NH.
FEBS Lett
View full abstract on Pubmed